OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Sold by Wasatch Advisors LP

Wasatch Advisors LP decreased its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 11.6% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 473,101 shares of the company's stock after selling 62,195 shares during the period. Wasatch Advisors LP owned approximately 1.95% of OrthoPediatrics worth $12,826,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the stock. International Assets Investment Management LLC increased its position in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock valued at $27,000 after acquiring an additional 966 shares during the period. Quest Partners LLC purchased a new position in shares of OrthoPediatrics in the second quarter worth about $34,000. BNP Paribas Financial Markets lifted its holdings in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock worth $94,000 after purchasing an additional 1,929 shares during the period. SG Americas Securities LLC acquired a new stake in shares of OrthoPediatrics during the second quarter worth about $110,000. Finally, Quantbot Technologies LP boosted its position in OrthoPediatrics by 42.2% in the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company's stock valued at $157,000 after buying an additional 1,712 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.

OrthoPediatrics Stock Performance

Shares of KIDS traded up $0.59 during trading hours on Friday, hitting $25.98. The stock had a trading volume of 73,343 shares, compared to its average volume of 202,861. The firm has a 50-day moving average price of $26.04 and a 200 day moving average price of $29.08. OrthoPediatrics Corp. has a fifty-two week low of $22.41 and a fifty-two week high of $36.23. The firm has a market capitalization of $629.24 million, a price-to-earnings ratio of -21.12 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

Analyst Ratings Changes

KIDS has been the subject of several research reports. Truist Financial decreased their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a "hold" rating for the company in a research note on Monday, October 14th. Needham & Company LLC restated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Friday, November 8th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.